Aurobindo Pharma Limited is pleased to announce the appointment of Arvind Vasudeva as Chief Executive Officer (Formulations) with effect from 22nd November, 2012.
Arvind Vasudeva is an M Pharm, Pharmaceutical Technology from Punjab University, Chandigarh and having almost three decades of experience in Formulations sales & marketing and business development. He brings close to 30 years of professional work experience primarily in pharma space, of which 15 years as Business Head / COO / CEO in leading Indian and global companies. He brings a strong business acumen and strategic thinking from his experience with several pharma companies.
Prior to joining Aurobindo, Arvind Vasudeva served as Chief Operating Officer at Glenmark Pharmaceuticals and was instrumental in the growth of the company. He also served as Managing Director of RPG Life Sciences, where he is credited in transforming the company into profitable operations. Prior to RPG Life Sciences, he served as President - Indian operations as well as Japan and ROW markets in Wockhardt.
Speaking on the occasion, K. Nithyananda Reddy, Vice Chairman of the Company said, "Aurobindo group is happy to welcome Arvind Vasudeva as an integral part of APL family. His expertise, professional capabilities and leadership will help the Company to strengthen its position in the Pharma space further."
India Infoline News Service / 09:04, Jan 22, 2015
The outlook is a flat start. The market will look to scale to new peaks though not much effort is needed for the same. HUL saw a rally and short-covering may have pulled it up further. Speculation is on that its parent will raise stake through an open offer. After the cooling in oil prices, Cairn results will be in focus.